RxDoctor Payments Data

Emily Santoli

Physician Assistant · Tampa, FLNPI 1205468600

Payments from drug & device makers

$819in general payments, 2019–2025

Across 31 payments — averaging $26.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$195
  • Medtronic$131
  • Sumitomo Pharma America, Inc.$128
  • AbbVie$54
  • Hollister Incorporated$50
  • ETS Wound Care LLC$44
  • plus $217 from 8 others

What the payments were for

  • Food & beverage$819100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)4$195
Medtronic2$131
Sumitomo Pharma America, Inc.5$128
AbbVie3$54
Hollister Incorporated2$50
ETS Wound Care LLC3$44
Astellas Pharma US Inc2$42
Dentsply IH Inc.2$37
Axonics, Inc.2$31
On Target Laboratories, Inc2$31
Coastal Medical Technologies LLC1$22
Teleflex LLC1$20
Inari Medical, Inc.1$18
Myriad Genetic Laboratories, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$819 in reported general payments places this provider in the 60th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$48,343
Medicare patients
226
Services billed
776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron77$67,157
MyrbetriqMirabegron34$41,338
Methenamine Hippurate69$7,043
Estradiol42$3,131
Solifenacin Succinate36$2,686
Potassium Citrate ErPotassium Citrate13$1,305
Oxybutynin Chloride ErOxybutynin Chloride18$1,129
Cefdinir49$1,109
Tamsulosin Hcl79$906
Alfuzosin Hcl ErAlfuzosin Hcl14$430
Ciprofloxacin Hcl41$272
Finasteride31$226
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$214
Fluconazole12$167
Cephalexin11$150

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$128$67,15777 claims
Astellas Pharma US IncMyrbetriq$42$41,33834 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →